相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events
Toshiaki Ohkuma et al.
DIABETOLOGIA (2018)
Type 2 diabetes, insulin treatment and prognosis of breast cancer
Lan Mu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells
Liuting Yang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer
Sherry X. Yang et al.
CANCER TREATMENT REVIEWS (2016)
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
Charles Guenancia et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection
Yunseon Choi et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Associations between diabetes medication use and risk of second breast cancer events and mortality
Gregory S. Calip et al.
CANCER CAUSES & CONTROL (2015)
Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress
Patrizia Ferroni et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Hee Jeong Kim et al.
BREAST CANCER RESEARCH (2015)
Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links
Valerio Gristina et al.
BIOMEDICAL REPORTS (2015)
Role of erbB3 receptors in cancer therapeutic resistance
Youngseok Lee et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
Is Cancer a Metabolic Disease?
Hilary A. Coller
AMERICAN JOURNAL OF PATHOLOGY (2014)
Long term survival of HER2-positive early breast cancer treated with trastuzumab-based adjuvant regimen: A large cohort study from clinical practice
Martina Bonifazi et al.
BREAST (2014)
Metabolic Syndrome and Breast Cancer: Is There a Link?
Dagmar Hauner et al.
BREAST CARE (2014)
Cancer as a metabolic disease: implications for novel therapeutics
Thomas N. Seyfried et al.
CARCINOGENESIS (2014)
The Effect of Radiation on the Immune Response to Cancers
Bonggoo Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Targeting of erbB3 receptor to overcome resistance in cancer treatment
Jian Ma et al.
MOLECULAR CANCER (2014)
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
Nicole M. Davis et al.
ONCOTARGET (2014)
Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
S. Jiralerspong et al.
ANNALS OF ONCOLOGY (2013)
Molecular subtypes of breast cancer: metabolic correlation with 18F-FDG PET/CT
Ana Maria Garcia Vicente et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis
Alberto Ocana et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women
Maria Theresa M. Redaniel et al.
CANCER CAUSES & CONTROL (2012)
Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer
Jiyoung Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Metabolic Syndrome and Triple-Negative Breast Cancer: A New Paradigm
Andrew A. Davis et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival A Study of 4046 Patients
Connie G. Chiu et al.
ANNALS OF SURGERY (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Diabetes and Cancer
T. A. Chowdhury
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer
Enrique de Alava et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
分享论文
